Borregaard ASA: Initiation of share repurchase programme
17 November 2023: Borregaard ASA ("Borregaard", OSE ticker: BRG)
Borregaard intends to repurchase up to 200,000 shares of its outstanding common stock. The shares will be used for employee incentive programmes. Borregaard’s Board of Directors was given authority by the shareholders at the Ordinary General Meeting held on 18 April 2023 to repurchase up to ten percent of the outstanding shares. According to the proxy, the highest price to be paid is NOK 400.00 per share.
The repurchase of shares will be conducted in a period from 20th November up to and including 20th December 2023 at the latest. The maximum daily volume to be purchased during the above-mentioned period is 23,843 shares. This limit corresponds to 25% of the average daily turnover in October 2023. All shares will be purchased in a regulated market.
Borregaard has appointed DNB Markets to carry out the repurchase programme according to the rules and regulations of Oslo Børs (cfr. Guidelines February 2021).
Lotte Kvinlaug, Investor Relations Officer, +47 922 86 909
This information is subject to the disclosure requirements pursuant to Regulation (EU) nr. 596/2014 on market abuse (MAR) Article 2 and Section 5-12 of the Norwegian Securities Trading Act.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
BBS-Bioactive Bone Substitutes Plc: Managers' Transactions - Pekka Jalovaara7.12.2023 18:00:00 CET | Press release
BBS-Bioactive Bone Substitutes Plc, Company announcement, Management transactions, 7 December 2023 at 7.00 p.m. (EET) BBS-Bioactive Bone Substitutes Oyj - Managers' Transactions – Pekka Jalovaara ____________________________________________ Person subject to the notification requirement Name: Jalovaara Pekka Position: Member of the Board/Deputy member Issuer: BBS Bioactive Bone Substitutes Oyj LEI: 743700BYSBP0PCR6N767 Notification type: INITIAL NOTIFICATION Reference number: 743700BYSBP0PCR6N767_20231207173757_8 ____________________________________________ Transaction date: 2023-12-04 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT ISIN: FI4000260583 Nature of the transaction: DISPOSAL Transaction details (1): Volume: 133,850 Unit price: 0.005 EUR Aggregated transactions (1): Volume: 133,850 Volume weighted average price: 0.005 EUR ____________________________________________ Transaction date: 2023-12-05 Venue not applicable Instrument
Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: publication of a transparency notification7.12.2023 18:00:00 CET | Press release
Dear Madam, Sir, Please find hereunder the links to Intervest Offices & Warehouses’ latest press release regarding the publication of a transparency notification. Geachte mevrouw, meneer, Gelieve hierbij de links te vinden naar het recente persbericht van Intervest Offices & Warehouses betreffende de openbaarmaking over transparantiekennisgeving. Chère Madame, Cher Monsieur, Veuillez trouver ci-dessous les liens vers le récent communiqué de presse d’Intervest Offices & Warehouses concernant la communication relative à une notification de transparence. Attachments ENG_transparency notification_20231201_FINNL_transparency notification_20231201_FINFR_transparency notification_20231201_FIN
75% Load Factor, 42% increase in passenger numbers and demand picking up7.12.2023 17:50:00 CET | Press release
75% Load Factor, 42% increase in passenger numbers and demand picking up PLAY airlines carried 107,236 passengers in November, which is a 42% increase from November 2022 when PLAY carried 75,396 passengers. The load factor in November 2023 was 74.5%, down from 79% last year. This decline in load factor is a direct result of the seismic activity in the Reykjanes Peninsula and resulting global news coverage of a possible volcanic eruption that could disrupt aviation. This situation impacted last-minute bookings in the month. PLAY had an on-time performance of 88.9% in November 2023. Despite the decline in load factor in November we continued to see year-on-year growth in our unit revenue (RASK), even with a 54% growth in available seat kilometers (ASK).Average ancillary revenue continues to rise for PLAY, being 30% higher in November 2023 compared to November 2022, and the trend is looking strong for the coming months. Of all passengers flying with PLAY in November 2023, 26.2% were depar
Innofactor Plc: Share Repurchase 7.12.20237.12.2023 17:30:00 CET | Press release
Innofactor Plc Announcement 7.12.2023Innofactor Plc: Share Repurchase 7.12.2023In the Helsinki Stock ExchangeTrade date 7.12.2023Bourse trade BuyShare IFA1VAmount 4,500SharesAverage price/ share 1.1494EURTotal cost 5,172.30EURInnofactor Plc now holds a total of 575 629 sharesincluding the shares repurchased on 7.12.2023On behalf of Innofactor PlcNordea Bank OyjJanne Sarvikivi Sami HuttunenAdditional information:Sami Ensio, CEOInnofactor PlcTel. +358 50 584 email@example.com Attachment Innofactor_7.12_trades
Coloplast A/S - Skift af revisor7.12.2023 17:29:40 CET | pressemeddelelse
I dag, den 7. december 2023, har Coloplast A/S afholdt ordinær generalforsamling, hvor EY Godkendt Revisionspartnerselskab blev valgt som Coloplast A/S’ revisor i overensstemmelse med forslaget fra bestyrelsen. For yderligere information, kontakt venligst Investorer og analytikere Anders Lonning-Skovgaard Koncerndirektør, CFO Tlf. 4911 1111 Aleksandra Dimovska Senior Director, Investor Relations Tlf. 4911 1800 / 4911 2458 E-mail: firstname.lastname@example.org Kristine Husted Munk Senior Manager, Investor Relations Tlf. 4911 1800 / 4911 3266 E-mail: email@example.com Presse og medier Peter Mønster Sr. Media Relations Manager Tlf. 4911 2623 Email: firstname.lastname@example.org Adresse Coloplast A/S Holtedam 1 3050 Humlebæk Danmark CVR Nr. 69749917 Hjemmeside www.coloplast.com Denne selskabsmeddelelse foreligger på dansk og engelsk. I tvivlstilfælde er den engelske version gældende. Coloplast blev grundlagt på passion, ambition og engagement. Vi opstod på grundlag af en sygeplejerskes ønske om at hjælpe